| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/17/2000 | EP1000626A1 Chemokine receptor antagonist and cyclosporin in combined therapy |
| 05/17/2000 | EP1000177A1 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus |
| 05/17/2000 | EP1000168A2 A swine hepatitis e virus and uses thereof |
| 05/17/2000 | EP1000166A2 Inhibitors of cell-cycle progression and uses related thereto |
| 05/17/2000 | EP1000165A1 Special virus dna fragments and their use as promoter |
| 05/17/2000 | EP1000164A1 Induction of male sterility in plants by expression of high levels of avidin |
| 05/17/2000 | EP1000163A1 $i(PSEUDOMONAS) EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS |
| 05/17/2000 | EP1000162A1 $i(PSEUDOMONAS) EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS FOR ELICITING A SECRETORY IGA-MEDIATED IMMUNE RESPONSE |
| 05/17/2000 | EP1000161A1 Anticoagulant fusion protein anchored to cell membrane |
| 05/17/2000 | EP1000158A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 05/17/2000 | EP1000157A1 Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
| 05/17/2000 | EP1000156A1 Bacillus thuringiensis cry6-toxins with improved activity |
| 05/17/2000 | EP1000155A1 Immunogenic fragments of toxin a of clostridium difficile |
| 05/17/2000 | EP1000154A1 Identification of human cell lines for the production of human proteins by endogenous gene activation |
| 05/17/2000 | EP1000153A2 Crustacean antimicrobial peptides |
| 05/17/2000 | EP1000152A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES |
| 05/17/2000 | EP1000151A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES |
| 05/17/2000 | EP1000150A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN |
| 05/17/2000 | EP1000149A2 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 05/17/2000 | EP1000148A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE |
| 05/17/2000 | EP1000147A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 05/17/2000 | EP1000146A2 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS |
| 05/17/2000 | EP1000145A1 Heart and skeleton muscle specific nucleic acid, the production and use thereof |
| 05/17/2000 | EP1000144A2 Lactoferrin receptor genes of moraxella |
| 05/17/2000 | EP1000143A1 Frazzled nucleotide sequences, expression products, compositions and uses |
| 05/17/2000 | EP1000089A1 Collagen type i and type iii adhesive compositions |
| 05/17/2000 | EP1000084A1 123 human secreted proteins |
| 05/17/2000 | EP1000083A1 Oxidized styrenic polymers for dna binding |
| 05/17/2000 | EP0999850A2 Methods and compositions for regulating nuclear trafficking of proteins |
| 05/17/2000 | EP0999849A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
| 05/17/2000 | EP0999848A1 Chimeric proteins for the treatment of diabetes |
| 05/17/2000 | EP0934425A4 Renilla luciferase and green fluorescent protein fusion genes |
| 05/17/2000 | EP0791011B1 Biologically active tgf-beta1 and tgf-beta2 peptides |
| 05/17/2000 | EP0785920B1 Multifunctional cross-linking reagents for hemoglobin, and cross-linked hemoglobin conjugates |
| 05/17/2000 | EP0773950A4 Linked peptide nucleic acids |
| 05/17/2000 | EP0620825B1 Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin |
| 05/17/2000 | EP0601106B1 Morphogen-induced modulation of inflammatory response |
| 05/17/2000 | CN1253589A Human complement C3-degrading proteinase from streptococcus pneumoniae |
| 05/17/2000 | CN1253586A Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription actor interactions |
| 05/17/2000 | CN1253567A Cell surface molecule mediating cell adhesion and signal transmission |
| 05/17/2000 | CN1253566A Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues |
| 05/17/2000 | CN1253565A Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 05/17/2000 | CN1253506A Chimeric flavirirus vaccines |
| 05/17/2000 | CN1253471A Insect control with hypersensitive response elicitor |
| 05/17/2000 | CN1253180A Specific protein of human neuroendocrine, coding sequence and its preparating process and application |
| 05/17/2000 | CN1253178A Protein correlative to obesity inhibin receptor, coding sequence and its preparing process and application |
| 05/17/2000 | CN1253176A Composition and method for protecting animals from diseases related with slow action virus |
| 05/17/2000 | CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase |
| 05/17/2000 | CN1052510C Mammalian receptors for interleukin-10 |
| 05/16/2000 | US6063987 Isolated genes and proteins encoding resistance to photosensitizers |
| 05/16/2000 | US6063983 Monoclonal lymphocytes and methods of use |
| 05/16/2000 | US6063913 Stable heterologous propagation CFTR protein variant cDNA |
| 05/16/2000 | US6063912 Amino acid sequence of homeobox protein; for screening abortion-inducing agents; diagnosis of related diseases; production of antibodies |
| 05/16/2000 | US6063910 Bringing droplets of liquid protein solution in a solvent into contact at controlled rate with excess of supercritical antisolvent which dissolves and expands liquid solution and precipitates dry protein particles; for time-release drugs |
| 05/16/2000 | US6063909 Preparation of factor IX |
| 05/16/2000 | US6063907 In vitro methods for determining in vivo thrombotic events |
| 05/16/2000 | US6063906 Antibodies to integrin alpha subunit |
| 05/16/2000 | US6063904 Isolated envelope protein with an amino acid sequence deletion; for efficient recombinant expression; for vaccines; for diagnostic reagents |
| 05/16/2000 | US6063903 Ligands for EPH-like receptors |
| 05/16/2000 | US6063902 Amino acid sequence of protein from fleas; for prevention/treatment of allergy dermatitis in animals; antiinflammatory agents; pesticides |
| 05/16/2000 | US6063901 Macrophage receptor with a collagenous domain |
| 05/16/2000 | US6063900 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 05/16/2000 | US6063767 Human phospholipid binding proteins |
| 05/16/2000 | US6063766 Drugs and proteins from blood with amino acid sequences |
| 05/16/2000 | US6063765 Bactericides against gram negative bacteria consiting of proteins |
| 05/16/2000 | US6063763 Enzyme inhibitors |
| 05/16/2000 | US6063761 Hepatoselective pharmaceutical actives |
| 05/16/2000 | US6063760 Proteins with amino acid sequences |
| 05/16/2000 | US6063758 Substance P-Saporin (SP-SAP) conjugates and methods of use thereof |
| 05/16/2000 | US6063756 Insecticidal polypeptides |
| 05/16/2000 | US6063755 Polypeptides with amino acid sequennces encoded by cdna clone |
| 05/16/2000 | US6063625 Regulated transcription of targeted genes and other biological events |
| 05/16/2000 | US6063623 Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, DNA sequences encoding it and their use |
| 05/16/2000 | US6063622 Adenovirus vectors |
| 05/16/2000 | US6063621 Hybridoma cell qcrl-1 having atcc accession number hb 11765; for production of monoclonal antibodies for use as antitumor agents and diagnostic reagents |
| 05/16/2000 | US6063613 Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof |
| 05/16/2000 | US6063612 Antiviral reagents based on RNA-binding proteins |
| 05/16/2000 | US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents |
| 05/16/2000 | US6063608 Cloned genes encoding reverse transcriptase lacking RNase H activity |
| 05/16/2000 | US6063605 Nucleotide sequences coding a protein that is and insecticide against lepidoptera, coleoptera and diptera |
| 05/16/2000 | US6063600 DNA encoding canine interleukin-1 receptor antagonist |
| 05/16/2000 | US6063599 Nucleic acid sequence of parasite polypeptide; for diagnosis of parasitic helminth infection; for the development of vaccines to prevent helminth and nematode infection |
| 05/16/2000 | US6063598 Strong homologous promoter obtained from hamsters |
| 05/16/2000 | US6063597 Polypeptide compositions toxic to coleopteran insects |
| 05/16/2000 | US6063596 G-protein coupled receptors associated with immune response |
| 05/16/2000 | US6063594 DNA encoding a novel human anion channel |
| 05/16/2000 | US6063592 Cleaving endothelins or vasoactive intestinal peptide with alloantigenic protein; incubating endothelins or vasoactive intestinal peptide with alloantigenic protein |
| 05/16/2000 | US6063585 Tumor necrosis factor receptor associated factor regulated protein product; for the prevention of tumors cause by epstein barr virus; antitumor agents |
| 05/16/2000 | US6063583 Detection of modulators which disrupt a regulatory complex; incubation of cells with modulators, monitoring cells and detecting reduction of gene expression of reporter molecule |
| 05/16/2000 | US6063582 Methods of screening for compounds that interact with human P2u2 purinergic receptor |
| 05/16/2000 | US6063576 Actin mutations in dilated cardiomyopathy, a heritable form of heart failure |
| 05/16/2000 | US6063569 Methods for automated synthesis of PNA-DNA chimeras and compositions thereof |
| 05/16/2000 | US6063566 Enzymatic ribonucleic acid molecule which catalyzes the position preferential cleavage of single-stranded deoxyribonucleic |
| 05/16/2000 | US6063427 Method for producing a hypoallergenic wheat flour |
| 05/16/2000 | US6063386 Recombinant multivalent M protein vaccine |
| 05/16/2000 | US6063384 Encapsidated recombinant viral nucleic acid and methods of making and using same |
| 05/16/2000 | US6063377 Rho protein |
| 05/16/2000 | US6063371 Co-administering interleukins and receptor to mammal |
| 05/16/2000 | US6063361 Administering to a patient at least one cascade polymer complex and subjecting the patient to a radiology diagnosis |
| 05/16/2000 | US6063297 Separation of blood cells from liquid suspension |